SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-049342
Filing Date
2014-08-13
Accepted
2014-08-13 16:10:40
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v385476_10q.htm 10-Q 309273
2 CERTIFICATION v385476_ex31-1.htm EX-31.1 10062
3 CERTIFICATION v385476_ex31-2.htm EX-31.2 10076
4 CERTIFICATION v385476_ex32-1.htm EX-32.1 4142
  Complete submission text file 0001144204-14-049342.txt   3912561

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT iliu-20140630.xml EX-101.INS 543353
6 XBRL TAXONOMY EXTENSION SCHEMA iliu-20140630.xsd EX-101.SCH 42509
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iliu-20140630_cal.xml EX-101.CAL 31930
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iliu-20140630_def.xml EX-101.DEF 220325
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE iliu-20140630_lab.xml EX-101.LAB 291023
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iliu-20140630_pre.xml EX-101.PRE 258105
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32715 | Film No.: 141037607
SIC: 2835 In Vitro & In Vivo Diagnostic Substances